Literature DB >> 6952211

Purification of a lymphoid cell line product with leukocyte inhibitory factor activity.

D H Meshulam, H E Blair, B L Wong, S Charm, J Minowada, R E Rocklin.   

Abstract

Leukocyte inhibitory factor (LIF), a lymphokine that inhibits the random and directed migration of polymorphonuclear (PMN) leukocytes, was purified from a human non-T, non-B leukemia cell line (Reh). From 10 liters of serum-free supernatant, 1.3 microgram of protein with LIF activity was obtained by the sequential use of affinity chromatography with concanavalin A-Sepharose, hydrophobic chromatography with hexylagarose, and gel filtration chromatography. The specific activity of LIF recovered represented an 80,000-fold purification over that of the initial crude serum-free supernatants, and the preparation at that point was estimated to be 80--90% pure. To both assess the purity of the preparation and provide a further purification step, Reh LIF activity recovered by the above procedures was subjected to isoelectric focusing. One major stainable protein band was identified; its isoelectric point was pH 5.4--5.5. Gels run in parallel for recovery of biologic activity revealed only one region (pH 5.4--5.5) with ability to inhibit PMN leukocyte migration. Iodination of Reh LIF resulted in a loss of biologic activity, but isoelectric focusing of this material revealed one major 125I-labeled band (pH 5.1) and several minor bands. The coincidence of biologic LIF activity with one stainable protein band as identified by isoelectric focusing implies that the final product may be homogeneous.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6952211      PMCID: PMC345793          DOI: 10.1073/pnas.79.2.601

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Amino acid analysis with fluorescamine at the picomole level.

Authors:  S Stein; P Böhlen; J Stone; W Dairman; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1973-03       Impact factor: 4.013

2.  Studies on the reaction of fluorescamine with primary amines.

Authors:  S De Bernardo; M Weigele; V Toome; K Manhart; W Leimgruber; P Böhlen; S Stein; S Udenfriend
Journal:  Arch Biochem Biophys       Date:  1974-07       Impact factor: 4.013

3.  Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.

Authors:  S Udenfriend; S Stein; P Böhlen; W Dairman; W Leimgruber; M Weigele
Journal:  Science       Date:  1972-11-24       Impact factor: 47.728

4.  Migration inhibitory effect of cell-free supernatants from mixed human lymphocyte cultures.

Authors:  J E Clausen
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

5.  Isoelectric focusing in polyacrylamide gels.

Authors:  P Righetti; J W Drysdale
Journal:  Biochim Biophys Acta       Date:  1971-04-27

6.  Partial characterization of leukocyte inhibitory factor by concanavalin A-stimulated human lymphocytes (LIF Con A).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

7.  Some physicochemical properties of human leucocyte migration inhibitory factor (LIF).

Authors:  K Bendtzen
Journal:  Acta Pathol Microbiol Scand C       Date:  1976-12

8.  Evidence that human leukocyte inhibitory factor (LIF) is an esterase.

Authors:  R E Rocklin; A S Rosenthal
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Human leukocyte migration inhibitory factor (LIF) III. Further investigations on the serine protease nature of this lymphokine and its preference for arginine amides.

Authors:  K Bendtzen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).

Authors:  R E Rocklin
Journal:  J Immunol       Date:  1974-04       Impact factor: 5.422

View more
  3 in total

1.  Physiological studies with human leukocyte inhibitory factor.

Authors:  L C Borish; R E Rocklin
Journal:  Surv Immunol Res       Date:  1985

2.  Potentiation of neutrophil aggregation by human leukocyte inhibitory factor.

Authors:  H Schainberg; L Borish; R E Rocklin
Journal:  Inflammation       Date:  1988-06       Impact factor: 4.092

3.  Two inhibitors of neutrophil chemotaxis are produced by hyperimmunoglobulin E recurrent infection syndrome mononuclear cells exposed to heat-killed staphylococci.

Authors:  H Donabedian; J I Gallin
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.